Natural Compounds Modulating Mitochondrial Functions

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Gibellini, Lara ^a   Bianchini, Elena ^a   De Biasi, Sara ^a   Nasi, Milena ^a   Cossarizza, Andrea ^a   Pinti, Marcello ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; CYTOCHROME C; MITOCHONDRIAL PROTEIN; NATURAL PRODUCT; PROTEIN BCL 2; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; TRANSCRIPTION FACTOR;

ANTIOXIDANT ACTIVITY; APOPTOSIS; BIOGENESIS; CANCER CELL; CELL FUNCTION; CELL PROLIFERATION; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MITOPHAGY; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; UPREGULATION;

EID: 84934301326     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/527209     Document Type: Review

References (157)

1. M. R. Duchen, "Mitochondria in health and disease: perspectives on a new mitochondrial biology", Molecular Aspects of Medicine, vol. 25, no. 4, pp. 365-451, 2004.
2. L. Galluzzi, O. Kepp, and G. Kroemer, "Mitochondria: master regulators of danger signalling", Nature Reviews Molecular Cell Biology, vol. 13, no. 12, pp. 780-788, 2012.
3. L. Galluzzi, O. Kepp, C. Trojel-Hansen, and G. Kroemer, "Mitochondrial control of cellular life, stress, and death", Circulation Research, vol. 111, no. 9, pp. 1198-1207, 2012.
4. L. Galluzzi, E. Morselli, O. Kepp, I. Vitale, M. Pinti, and G. Kroemer, "Mitochondrial liaisons of p53", Antioxidants & Redox Signaling, vol. 15, no. 6, pp. 1691-1714, 2011.
5. 2 signaling", Antioxidants & Redox Signaling, vol. 14, no. 3, pp. 459-468, 2011.
6. D. C. Wallace, "A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine", Annual Review of Genetics, vol. 39, pp. 359-407, 2005.
7. M. Pinti, C. Mussini, and A. Cossarizza, "Mitochondrial DNA: a proinflammatory 'enemy fromwithin' during HIV infection?" Cell Death and Disease, vol. 3, no. 5, article e307, 2012.
8. G. Sgarbi, P. Matarrese, M. Pinti et al., "Mitochondria hyperfusion and elevated autophagic activity are key mechanisms for cellular bioenergetic preservation in centenarians", Aging, vol. 6, no. 4, pp. 296-310, 2014.
9. D. Monti, S. Salvioli, M. Capri et al., "Decreased susceptibility to oxidative stress-induced apoptosis of peripheral blood mononuclear cells from healthy elderly and centenarians", Mechanisms of Ageing and Development, vol. 121, no. 1-3, pp. 239-250, 2001.
10. R. Ferraresi, L. Troiano, M. Pinti et al., "Resistance of mt DNAdepleted cells to apoptosis", Cytometry A, vol. 73, no. 6, pp. 528-537, 2008.
11. L. Gibellini, M. Pinti, M. Nasi et al., "Interferingwith ROS metabolism in cancer cells: the potential role of quercetin", Cancers, vol. 2, no. 2, pp. 1288-1311, 2010.
12. C. Giordano, M. Sebastiani, G. Plazzi et al., "Mitochondrial neurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine", Gastroenterology, vol. 130, no. 3, pp. 893-901, 2006.
13. G. Kroemer, L. Galluzzi, and C. Brenner, "Mitochondrial membrane permeabilization in cell death", Physiological Reviews, vol. 87, no. 1, pp. 99-163, 2007.
14. S. Fulda, L. Galluzzi, and G. Kroemer, "Targeting mitochondria for cancer therapy", Nature Reviews Drug Discovery, vol. 9, no. 6, pp. 447-464, 2010.
15. A. Cossarizza, G. Kalashnikova, E. Grassilli et al., "Mitochondrial modifications during rat thymocyte apoptosis: a study at the single cell level", Experimental Cell Research, vol. 214, no. 1, pp. 323-330, 1994.
16. M. Garcia Fernandez, L. Troiano, L. Moretti et al., "Early changes in intramitochondrial cardiolipin distribution during apoptosis", Cell Growth and Differentiation, vol. 13, no. 9, pp. 449-455, 2002.
17. D. Monti, E. Grassilli, L. Troiano et al., "Senescence, immortalization, and apoptosis: an intriguing relationship", Annals of the New York Academy of Sciences, vol. 673, pp. 70-82, 1992.
18. M. Pinti, P. Salomoni, and A. Cossarizza, "Anti-HIV drugs and themitochondria", Biochimica et Biophysica Acta: Bioenergetics, vol. 1757, no. 5-6, pp. 700-707, 2006.
19. J. R. Gledhill, M. G. Montgomery, A. G. W. Leslie, and J. E. Walker, "Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols", Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 34, pp. 13632-13637, 2007.
20. J. R. Gledhill and J. E. Walker, "Inhibition sites in F1-ATPase frombovine heartmitochondria", Biochemical Journal, vol. 386, part 3, pp. 591-598, 2005.
21. J. L. Kipp and V. D. Ramirez, "Effect of estradiol, diethylstilbestrol, and resveratrol on F0F1-ATPase activity from mitochondrial preparations of rat heart, liver, and brain", Endocrine, vol. 15, no. 2, pp. 165-175, 2001.
22. M. Sekiya, R. Hisasaka, A. Iwamoto-Kihara, M. Futai, and M. Nakanishi-Matsui, "A unique mechanism of curcumin inhibition on F1 ATPase", Biochemical and Biophysical Research Communications, vol. 452, no. 4, pp. 940-944, 2014.
23. J. Zheng and V. D. Ramirez, "Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals", British Journal of Pharmacology, vol. 130, no. 5, pp. 1115-1123, 2000.
24. P. C. H. Hollman and M. B. Katan, "Dietary flavonoids: Intake, health effects and bioavailability", Food and Chemical Toxicology, vol. 37, no. 9-10, pp. 937-942, 1999.
25. L. Gibellini, M. Pinti, M. Nasi et al., "Quercetin and cancer chemoprevention", Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 591356, 15 pages, 2011.
26. B. B. Aggarwal, A. Kumar, and A. C. Bharti, "Anticancer potential of curcumin: preclinical and clinical studies", Anticancer Research, vol. 23, no. 1, pp. 363-398, 2003.
27. V. Basile, E. Ferrari, S. Lazzari, S. Belluti, F. Pignedoli, and C. Imbriano, "Curcumin derivatives: molecular basis of their anticancer activity", Biochemical Pharmacology, vol. 78, no. 10, pp. 1305-1315, 2009.
28. R. P. Sahu, S. Batra, and S. K. Srivastava, "Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells", British Journal of Cancer, vol. 100, no. 9, pp. 1425-1433, 2009.
29. S.-H. Jee, S.-C. Shen, C.-R. Tseng, H.-C. Chiu, and M.-L. Kuo, "Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells", Journal of Investigative Dermatology, vol. 111, no. 4, pp. 656-661, 1998.
30. T. Kawamori, R. Lubet, V. E. Steele et al., "Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer", Cancer Research, vol. 59, no. 3, pp. 597-601, 1999.
31. K. Mehta, P. Pantazis, T. McQueen, and B. B. Aggarwal, "Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines", Anti-Cancer Drugs, vol. 8, no. 5, pp. 470-481, 1997.
32. R. Hayun, E. Okun, A. Berrebi et al., "Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells", Leukemia and Lymphoma, vol. 50, no. 4, pp. 625-632, 2009.
33. S. Purkayastha, A. Berliner, S. S. Fernando et al., "Curcumin blocks brain tumor formation", Brain Research, vol. 1266, pp. 130-138, 2009.
34. M. Sekiya, E. Chiba, M. Satoh et al., "Strong inhibitory effects of curcumin and its demethoxy analog on Escherichia coli ATP synthase F1 sector", International Journal of Biological Macromolecules, vol. 70, pp. 241-245, 2014.
35. 1-ATpase", The Journal of Biological Chemistry, vol. 287, no. 27, pp. 22771-22780, 2012.
36. M. Fiorani, A. Guidarelli, M. Blasa et al., "Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid", Journal of Nutritional Biochemistry, vol. 21, no. 5, pp. 397-404, 2010.
37. D. R. Lang and E. Racker, "Effects of quercetin and F1 inhibitor on mitochondrial ATPase and energy-linked reactions in submitochondrial particles", Biochimica et Biophysica Acta, vol. 333, no. 2, pp. 180-186, 1974.
38. R. Ortega and N. García, "The flavonoid quercetin induces changes in mitochondrial permeability by inhibiting adenine nucleotide translocase", Journal of Bioenergetics and Biomembranes, vol. 41, no. 1, pp. 41-47, 2009.
39. D. J. Dorta, A. A. Pigoso, F. E. Mingatto et al., "The interaction of flavonoidswithmitochondria: effects on energetic processes", Chemico-Biological Interactions, vol. 152, no. 2-3, pp. 67-78, 2005.
40. S. Trumbeckaite, J. Bernatoniene, D. Majiene, V. Jakštas, A. Savickas, and A. Toleikis, "The effect of flavonoids on rat heart mitochondrial function", Biomedicine and Pharmacotherapy, vol. 60, no. 5, pp. 245-248, 2006.
41. M. Lagouge, C. Argmann, Z. Gerhart-Hines et al., "Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α", Cell, vol. 127, no. 6, pp. 1109-1122, 2006.
42. T. Murase, S. Haramizu, N. Ota, and T. Hase, "Suppression of the aging-associated decline in physical performance by a combination of resveratrol intake and habitual exercise in senescence-accelerated mice", Biogerontology, vol. 10, no. 4, pp. 423-434, 2009.
43. N. Hart, L. Sarga, Z. Csende et al., "Resveratrol attenuates exerciseinduced adaptive responses in rats selectively bred for low running performance", Dose-Response, vol. 12, no. 1, pp. 57-71, 2014.
44. N. Hart, L. Sarga, Z. Csende et al., "Resveratrol enhances exercise training responses in rats selectively bred for high running performance", Food and Chemical Toxicology, vol. 61, pp. 53-59, 2013.
45. H. W. Lim, H. Y. Lim, and K. P. Wong, "Uncoupling of oxidative phosphorylation by curcumin: implication of its cellular mechanism of action", Biochemical and Biophysical Research Communications, vol. 389, no. 1, pp. 187-192, 2009.
46. B. Chance and G. Hollunger, "The interaction of energy and electron transfer reactions in mitochondria. I. General properties and nature of the products of succinate-linked reduction of pyridine nucleotide", The Journal of Biological Chemistry, vol. 236, pp. 1534-1543, 1961.
47. E. B. Tahara, F. D. T. Navarete, and A. J. Kowaltowski, "Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation", Free Radical Biology and Medicine, vol. 46, no. 9, pp. 1283-1297, 2009.
48. C. G. M. Heijnen, G. R. M. M. Haenen, F. A. A. van Acker, W. J. F. van der Vijgh, and A. Bast, "Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups", Toxicology in Vitro, vol. 15, no. 1, pp. 3-6, 2001.
49. D. Metodiewa, A. K. Jaiswal, N. Cenas, E. Dickancaité, and J. Segura-Aguilar, "Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product", Free Radical Biology and Medicine, vol. 26, no. 1-2, pp. 107-116, 1999.
50. M. Yoshino, M. Haneda, M. Naruse, and K. Murakami, "Prooxidant activity of flavonoids: copper-dependent strand breaks and the formation of 8-hydroxy-2'-deoxyguanosine in DNA", Molecular Genetics and Metabolism, vol. 68, no. 4, pp. 468-472, 1999.
51. A. M. Ramos and P. Aller, "Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines", Biochemical Pharmacology, vol. 75, no. 10, pp. 1912-1923, 2008.
52. R. Ferraresi, L. Troiano, E. Roat et al., "Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin", Free Radical Research, vol. 39, no. 11, pp. 1249-1258, 2005.
53. R. Kachadourian and B. J. Day, "Flavonoid-induced glutathione depletion: potential implications for cancer treatment", Free Radical Biology and Medicine, vol. 41, no. 1, pp. 65-76, 2006.
54. A. W. Boots, N. Kubben, G. R. M. M. Haenen, and A. Bast, "Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation", Biochemical and Biophysical Research Communications, vol. 308, no. 3, pp. 560-565, 2003.
55. S. C. Sahu and G. C. Gray, "Pro-oxidant activity of flavanoids: effects on glutathione and glutathione S-transferase in isolated rat liver nuclei", Cancer Letters, vol. 104, no. 2, pp. 193-196, 1996.
56. J. Lu, L. V. Papp, J. Fang, S. Rodriguez-Nieto, B. Zhivotovsky, and A. Holmgren, "Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity", Cancer Research, vol. 66, no. 8, pp. 4410-4418, 2006.
57. J. D. Hayes and A. T. Dinkova-Kostova, "The Nrf2 regulatory network provides an interface between redox and intermediary metabolism", Trends in Biochemical Sciences, vol. 39, no. 4, pp. 199-218, 2014.
58. K. Itoh, P. Ye, T. Matsumiya, K. Tanji, and T. Ozaki, "Emerging functional cross-talk between the Keap1-Nrf2 system andmitochondria", Journal of Clinical Biochemistry and Nutrition, vol. 56, no. 2, pp. 91-97, 2015.
59. A. B. Granado-Serrano, M. A. Martín, L. Bravo, L. Goya, and S. Ramos, "Quercetin modulates Nrf2 and glutathionerelated defenses in Hep G2 cells: involvement of p38", Chemico-Biological Interactions, vol. 195, no. 2, pp. 154-164, 2012.
60. S. Tanigawa, M. Fujii, and D.-X. Hou, "Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin", Free Radical Biology and Medicine, vol. 42, no. 11, pp. 1690-1703, 2007.
61. J. Sanhueza, J. Valdes, R. Campos, A. Garrido, and A. Valenzuela, "Changes in the xanthine dehydrogenase/xanthine oxidase ratio in the rat kidney subjected to ischemia-reperfusion stress: preventive effect of some flavonoids", Research Communications in Chemical Pathology and Pharmacology, vol. 78, no. 2, pp. 211-218, 1992.
62. O. Çevik, S. Çadrc, T. E. Şener et al., "Quercetin treatment against ischemia/reperfusion injury in rat corpus cavernosum tissue: a role on apoptosis and oxidative stress", Free Radical Research, vol. 47, no. 9, pp. 683-691, 2013.
63. A. Ghosh, S. Sarkar, A. K. Mandal, and N. Das, "Neuroprotective role of nanoencapsulated quercetin in combating ischemiareperfusion induced neuronal damage in young and aged rats", PLoS ONE, vol. 8, no. 4, Article ID e57735, 2013.
64. P. Lorenz, S. Roychowdhury, M. Engelmann, G. Wolf, and T. F. W. Horn, "Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived frommicroglial cells", Nitric Oxide: Biology and Chemistry, vol. 9, no. 2, pp. 64-76, 2003.
65. P. Guha, A. Dey, M. V. Dhyani et al., "Calpain and caspase orchestrated death signal to accomplish apoptosis induced by resveratrol and its novel analog hydroxstilbene-1 in cancer cells", Journal of Pharmacology and Experimental Therapeutics, vol. 334, no. 2, pp. 381-394, 2010.
66. S. S. Leonard, C. Xia, B.-H. Jiang et al., "Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses", Biochemical and Biophysical Research Communications, vol. 309, no. 4, pp. 1017-1026, 2003.
67. L.-M. Hung, M.-J. Su, W.-K. Chu, C.-W. Chiao, W.-F. Chan, and J.-K. Chen, "The protective effect of resveratrols on ischaemiareperfusion injuries of rat hearts is correlated with antioxidant efficacy", British Journal of Pharmacology, vol. 135, no. 7, pp. 1627-1633, 2002.
68. Y.-G. Li, W. Zhu, J.-P. Tao et al., "Resveratrol protects cardiomyocytes from oxidative stress through SIRT1 and mitochondrial biogenesis signaling pathways", Biochemical and Biophysical Research Communications, vol. 438, no. 2, pp. 270-276, 2013.
69. M. Shen, R.-X. Wu, L. Zhao et al., "Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism", PLoS ONE, vol. 7, no. 12, Article ID e51223, 2012.
70. H. Zheng, H. Guo, Y. Hong, F. Zheng, and J. Wang, "The effects of age and resveratrol on the hypoxic preconditioning protection against hypoxia-reperfusion injury: studies in rat hearts and human cardiomyocytes", European Journal of Cardio-Thoracic Surgery, 2015.
71. E. Hirzel, P. W. Lindinger, S. Maseneni et al., "Differential modulation of ROS signals and othermitochondrial parameters by the antioxidants Mito Q, resveratrol and curcumin in human adipocytes", Journal of Receptors and Signal Transduction, vol. 33, no. 5, pp. 304-312, 2013.
72. B. Bellaver, D. G. Souza, D. O. Souza, and A. Quincozes-Santos, "Resveratrol increases antioxidant defenses and decreases proinflammatory cytokines in hippocampal astrocyte cultures from newborn, adult and aged Wistar rats", Toxicology in Vitro, vol. 28, no. 4, pp. 479-484, 2014.
73. J. Soeur, J. Eilstein, G. Léreaux, C. Jones, and L. Marrot, "Skin resistance to oxidative stress induced by resveratrol: from Nrf2 activation to GSH biosynthesis", Free Radical Biology and Medicine, vol. 78, pp. 213-223, 2015.
74. X. Zhou, M. Chen, X. Zeng et al., "Resveratrol regulates mitochondrial reactive oxygen species homeostasis through Sirt3 signaling pathway in human vascular endothelial cells", Cell Death and Disease, vol. 5, no. 12, Article IDe1576, 2014.
75. Z. Ungvari, Z. Bagi, A. Feher et al., "Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2", American Journal of Physiology-Heart and Circulatory Physiology, vol. 299, no. 1, pp. H18-H24, 2010.
76. Z. Ungvari, Z. Orosz, A. Rivera et al., "Resveratrol increases vascular oxidative stress resistance", The American Journal of Physiology-Heart and Circulatory Physiology, vol. 292, no. 5, pp. H2417-H2424, 2007.
77. Z. Ungvari, N. Labinskyy, P. Mukhopadhyay et al., "Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells", The American Journal of Physiology-Heart and Circulatory Physiology, vol. 297, no. 5, pp. H1876-H1881, 2009.
78. W.-H. Chan, H.-J. Wu, and Y.-D. Hsuuw, "Curcumin inhibits ROS formation and apoptosis in methylglyoxal-treated human hepatoma G2 cells", Annals of the New York Academy of Sciences, vol. 1042, pp. 372-378, 2005.
79. J. M. Woo, D.-Y. Shin, S. J. Lee et al., "Curcumin protects retinal pigment epithelial cells against oxidative stress via induction of heme oxygenase-1 expression and reduction of reactive oxygen", Molecular Vision, vol. 18, pp. 901-908, 2012.
80. H. Jiang, X. Tian, Y. Guo, W. Duan, H. Bu, and C. Li, "Activation of nuclear factor erythroid 2-related factor 2 cytoprotective signaling by curcumin protect primary spinal cord astrocytes against oxidative toxicity", Biological and Pharmaceutical Bulletin, vol. 34, no. 8, pp. 1194-1197, 2011.
81. P. Manikandan, M. Sumitra, S. Aishwarya, B. M. Manohar, B. Lokanadam, and R. Puvanakrishnan, "Curcumin modulates free radical quenching in myocardial ischaemia in rats", The International Journal of Biochemistry & Cell Biology, vol. 36, no. 10, pp. 1967-1980, 2004.
82. T. Ak and I. Gülçin, "Antioxidant and radical scavenging properties of curcumin", Chemico-Biological Interactions, vol. 174, no. 1, pp. 27-37, 2008.
83. S. Derochette, T. Franck, A. Mouithys-Mickalad et al., "Curcumin and resveratrol act by different ways on NADPH oxidase activity and reactive oxygen species produced by equine neutrophils", Chemico-Biological Interactions, vol. 206, no. 2, pp. 186-193, 2013.
84. A. Barzegar and A. A. Moosavi-Movahedi, "Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin", PLoS ONE, vol. 6, no. 10, Article IDe26012, 2011.
85. J. E. Kim, A. R. Kim, H. Y. Chung, S. Y. Han, B. S. Kim, and J. S. Choi, "In vitro peroxynitrite scavenging activity of diarylheptanoids from Curcuma longa", Phytotherapy Research, vol. 17, no. 5, pp. 481-484, 2003.
86. Y. Sumanont, Y. Murakami, M. Tohda, O. Vajragupta, K. Matsumoto, and H. Watanabe, "Evaluation of the nitric oxide radical scavenging activity of manganese complexes of curcumin and its derivative", Biological and Pharmaceutical Bulletin, vol. 27, no. 2, pp. 170-173, 2004.
87. H. D. Panchal, K. Vranizan, C. Y. Lee, J. Ho, J. Ngai, and P. S. Timiras, "Early anti-oxidative and anti-proliferative curcumin effects on neuroglioma cells suggest therapeutic targets", Neurochemical Research, vol. 33, no. 9, pp. 1701-1710, 2008.
88. G. S. Jeong, G. S. Oh, H. O. Pae et al., "Comparative effects of curcuminoids on endothelial heme oxygenase-1 expression: ortho-methoxy groups are essential to enhance heme oxygenase activity and protection", Experimental & Molecular Medicine, vol. 38, no. 4, pp. 393-400, 2006.
89. L. M. Reyes-Fermín, S. González-Reyes, N. G. Tarco-Álvarez, M. Hernández-Nava, M. Orozco-Ibarra, and J. Pedraza-Chaverri, "Neuroprotective effect of α-mangostin and curcumin against iodoacetate-induced cell death", Nutritional Neuroscience, vol. 15, no. 5, pp. 34-41, 2012.
90. L. P. Yarru, R. S. Settivari, N. K. S. Gowda, E. Antoniou, D. R. Ledoux, and G. E. Rottinghaus, "Effects of turmeric (Curcuma longa) on the expression of hepatic genes associated with biotransformation, antioxidant, and immune systems in broiler chicks fed aflatoxin", Poultry Science, vol. 88, no. 12, pp. 2620-2627, 2009.
91. E. Balogun, R. Foresti, C. J. Green, and R. Motterlini, "Changes in temperature modulate heme oxygenase-1 induction by curcumin in renal epithelial cells", Biochemical and Biophysical Research Communications, vol. 308, no. 4, pp. 950-955, 2003.
92. E. Balogun, M. Hoque, P. Gong et al., "Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element", Biochemical Journal, vol. 371, no. 3, pp. 887-895, 2003.
93. S. Gao, X. Duan, X. Wang et al., "Curcumin attenuates arsenicinduced hepatic injuries and oxidative stress in experimental mice through activation of Nrf2 pathway, promotion of arsenic methylation and urinary excretion", Food and Chemical Toxicology, vol. 59, pp. 739-747, 2013.
94. R. Garg, S. Gupta, and G. B. Maru, "Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[α]pyrene-treated mice: mechanism of its antiinitiating action", Carcinogenesis, vol. 29, no. 5, pp. 1022-1032, 2008.
95. A. González-Salazar, E. Molina-Jijón, F. Correa et al., "Curcumin protects fromcardiac reperfusion damage by attenuation of oxidant stress and mitochondrial dysfunction", Cardiovascular Toxicology, vol. 11, no. 4, pp. 357-364, 2011.
96. F. Correa, M. Buelna-Chontal, S. Hernández-Reséndiz et al., "Curcumin maintains cardiac and mitochondrial function in chronic kidney disease", Free Radical Biology and Medicine, vol. 61, pp. 119-129, 2013.
97. E. Molina-Jijón, E. Tapia, C. Zazueta et al., "Curcumin prevents Cr (VI)-induced renal oxidant damage by amitochondrial pathway", Free Radical Biology and Medicine, vol. 51, no. 8, pp. 1543-1557, 2011.
98. A. K. Chandra, A. Chatterjee, R. Ghosh, and M. Sarkar, "Effect of curcumin on chromium-induced oxidative damage in male reproductive system", Environmental Toxicology and Pharmacology, vol. 24, no. 2, pp. 160-166, 2007.
99. W. R. García-Niño, E. Tapia, C. Zazueta et al., "Curcumin pretreatment prevents potassium dichromate-induced hepatotoxicity, oxidative stress, decreased respiratory complex I activity, and membrane permeability transition pore opening", Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 424692, 19 pages, 2013.
100. N. Sivalingam, J. Basivireddy, K. A. Balasubramanian, and M. Jacob, "Curcumin attenuates indomethacin-induced oxidative stress and mitochondrial dysfunction", Archives of Toxicology, vol. 82, no. 7, pp. 471-481, 2008.
101. S. Fulda, "Modulation of apoptosis by natural products for cancer therapy", Planta Medica, vol. 76, no. 11, pp. 1075-1079, 2010.
102. N. Rayamajhi, S.-K. Kim, H. Go et al., "Quercetin induces mitochondrial biogenesis through activation of HO-1 in Hep G2 cells", Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 154279, 10 pages, 2013.
103. D. C. Nieman, A. S. Williams, R. A. Shanely et al., "Quercetin's influence on exercise performance and muscle mitochondrial biogenesis", Medicine and Science in Sports and Exercise, vol. 42, no. 2, pp. 338-345, 2010.
104. S. M. Kwon, H. G. Park, J. K. Jun, and W. L. Lee, "Exercise, but not quercetin, ameliorates inflammation, mitochondrial biogenesis, and lipidmetabolism in skeletalmuscle after strenuous exercise by high-fat diet mice", The Journal of Exercise Nutrition and Biochemistry, vol. 6, no. 1, pp. 51-60, 1975.
105. R. A. Casuso, E. J. Martínez-López, F. Hita-Contreras et al., "The combination of oral quercetin supplementation and exercise prevents brain mitochondrial biogenesis", Genes & Nutrition, vol. 9, no. 5, p. 420, 2014.
106. T.-J. Lee, O. H. Kim, Y. H. Kim et al., "Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells", Cancer Letters, vol. 240, no. 2, pp. 234-242, 2006.
107. J.-H. Yang, T.-C. Hsia, H.-M. Kuo et al., "Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis", Drug Metabolism and Disposition, vol. 34, no. 2, pp. 296-304, 2006.
108. S.-Y. Chien, Y.-C. Wu, J.-G. Chung et al., "Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells", Human and Experimental Toxicology, vol. 28, no. 8, pp. 493-503, 2009.
109. A. B. Granado-Serrano, M. A. Martín, L. Bravo, L. Goya, and S. Ramos, "Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (Hep G2)", Journal of Nutrition, vol. 136, no. 11, pp. 2715-2721, 2006.
110. J. Tan, B. Wang, and L. Zhu, "Regulation of survivin and Bcl-2 in Hep G2 cell apoptosis induced by quercetin", Chemistry and Biodiversity, vol. 6, no. 7, pp. 1101-1110, 2009.
111. L. Troiano, R. Ferraresi, E. Lugli et al., "Multiparametric analysis of cells with different mitochondrial membrane potential during apoptosis by polychromatic flow cytometry", Nature Protocols, vol. 2, no. 11, pp. 2719-2727, 2007.
112. E. Lugli, R. Ferraresi, E. Roat et al., "Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells", Leukemia Research, vol. 33, no. 1, pp. 140-150, 2009.
113. J.-H. Jeong, J. Y. An, Y. T. Kwon, J. G. Rhee, and Y. J. Lee, "Effects of lowdose quercetin: cancer cell-specific inhibition of cell cycle progression", Journal of Cellular Biochemistry, vol. 106, no. 1, pp. 73-82, 2009.
114. Y.-K. Lee, J.-T. Hwang, D. Y. Kwon, Y.-J. Surh, and O. J. Park, "Induction of apoptosis by quercetin is mediated through AMPKα1/ASK1/p38 pathway", Cancer Letters, vol. 292, no. 2, pp. 228-236, 2010.
115. A. Matsuzawa and H. Ichijo, "Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling", Biochimica et Biophysica Acta-General Subjects, vol. 1780, no. 11, pp. 1325-1336, 2008.
116. Y.-K. Lee, Y. P. Song, Y.-M. Kim, S. L. Won, and J. P. Ock, "AMP kinase/cyclooxygenase-2 pathway regulates proliferation and apoptosis of cancer cells treated with quercetin", Experimental and Molecular Medicine, vol. 41, no. 3, pp. 201-207, 2009.
117. G. T. Kim, S. H. Lee, and Y. M. Kim, "Quercetin regulates sestrin 2-AMPK-m TOR signaling pathway and induces apoptosis via increased intracellular ROS in HCT116 colon cancer cells", Journal of Cancer Prevention, vol. 18, no. 3, pp. 264-270, 2013.
118. J.-H. Um, S.-J. Park, H. Kang et al., "AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol", Diabetes, vol. 59, no. 3, pp. 554-563, 2010.
119. K. J. Menzies, K. Singh, A. Saleem, and D. A. Hood, "Sirtuin 1-mediated effects of exercise and resveratrol on mitochondrial biogenesis", The Journal of Biological Chemistry, vol. 288, no. 10, pp. 6968-6979, 2013.
120. S. Chung, H. Yao, S. Caito, J.-W. Hwang, G. Arunachalam, and I. Rahman, "Regulation of SIRT1 in cellular functions: role of polyphenols", Archives of Biochemistry and Biophysics, vol. 501, no. 1, pp. 79-90, 2010.
121. K. T. Howitz, K. J. Bitterman, H. Y. Cohen et al., "Smallmolecule activators of sirtuins extend Saccharomyces cerevisiae lifespan", Nature, vol. 425, no. 6954, pp. 191-196, 2003.
122. M. Pacholec, J. E. Bleasdale, B. Chrunyk et al., "SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1", Journal of Biological Chemistry, vol. 285, no. 11, pp. 8340-8351, 2010.
123. D. Beher, J. Wu, S. Cumine et al., "Resveratrol is not a direct activator of SIRT1 enzyme activity", Chemical Biology and Drug Design, vol. 74, no. 6, pp. 619-624, 2009.
124. K. Higashida, S. H. Kim, S. R. Jung, M. Asaka, J. O. Holloszy, and D.-H. Han, "Effects of resveratrol and SIRT1 on PGC-1α activity and mitochondrial biogenesis: a reevaluation", PLoS Biology, vol. 11, no. 7, Article ID e1001603, 2013.
125. D. Sareen, S. R. Darjatmoko, D. M. Albert, and A. S. Polans, "Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer", Molecular Pharmacology, vol. 72, no. 6, pp. 1466-1475, 2007.
126. 2+ andm CICR-mediated MPT activation in Hep G2 cells", Molecular and Cellular Biochemistry, vol. 302, no. 1-2, pp. 99-109, 2007.
127. S. Fulda and K.-M. Debatin, "Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol", Cancer Research, vol. 64, no. 1, pp. 337-346, 2004.
128. A. R. Jazirehi and B. Bonavida, "Resveratrolmodifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxelinduced apoptosis", Molecular Cancer Therapeutics, vol. 3, no. 1, pp. 71-84, 2004.
129. A. Bhardwaj, G. Sethi, S. Vadhan-Raj et al., "Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factorkappa B-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells", Blood, vol. 109, no. 6, pp. 2293-2302, 2007.
130. J.-W. Park, Y.-J. Choi, S.-I. Suh et al., "Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity", Carcinogenesis, vol. 22, no. 10, pp. 1633-1639, 2001.
131. L. Tessitore, A. Davit, I. Sarotto, and G. Caderni, "Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21 (CIP) expression", Carcinogenesis, vol. 21, no. 8, pp. 1619-1622, 2000.
132. M. Mahyar-Roemer, A. Katsen, P. Mestres, and K. Roemer, "Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse", International Journal of Cancer, vol. 94, no. 5, pp. 615-622, 2001.
133. M. Mahyar-Roemer, H. Köhler, and K. Roemer, "Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells", BMC Cancer, vol. 2, no. 1, article 27, 2002.
134. J.-J. Kuo, H.-H. Chang, T.-H. Tsai, and T.-Y. Lee, "Curcumin ameliorates mitochondrial dysfunction associated with inhibition of gluconeogenesis in free fatty acid-mediated hepatic lipoapoptosis", International Journal of Molecular Medicine, vol. 30, no. 3, pp. 643-649, 2012.
135. J. Cao, L. Jia, H.-M. Zhou, Y. Liu, and L.-F. Zhong, "Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells", Toxicological Sciences, vol. 91, no. 2, pp. 476-483, 2006.
136. Y. Kim, H. D. Kim, and J. Kim, "Cytoplasmic ribosomal protein S3 (rp S3) plays a pivotal role in mitochondrial DNA damage surveillance", Biochimica et Biophysica Acta, vol. 1833, no. 12, pp. 2943-2952, 2013.
137. J. Cao, Y. Liu, L. Jia et al., "Curcumin induces apoptosis through mitochondrial hyperpolarization and mt DNA damage in human hepatoma G2 cells", Free Radical Biology and Medicine, vol. 43, no. 6, pp. 968-975, 2007.
138. L. Liu, W. Zhang, L. Wang et al., "Curcumin prevents cerebral ischemia reperfusion injury via increase of mitochondrial biogenesis", Neurochemical Research, vol. 39, no. 7, pp. 1322-1331, 2014.
139. L. Li, B. B. Aggarwal, S. Shishodia, J. Abbruzzese, and R. Kurzrock, "Nuclear factor-κB and IκB are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis", Cancer, vol. 101, no. 10, pp. 2351-2362, 2004.
140. J. L. Watson, R. Hill, P. B. Yaffe et al., "Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells", Cancer Letters, vol. 297, no. 1, pp. 1-8, 2010.
141. D. Morin, S. Barthélémy, R. Zini, S. Labidalle, and J.-P. Tillement, "Curcumin induces themitochondrial permeability transition pore mediated by membrane protein thiol oxidation", FEBS Letters, vol. 495, no. 1-2, pp. 131-136, 2001.
142. S. Karmakar, N. L. Banik, S. J. Patel, and S. K. Ray, "Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells", Neuroscience Letters, vol. 407, no. 1, pp. 53-58, 2006.
143. R. Gogada, M. Amadori, H. Zhang et al., "Curcumin induces Apaf-1-dependent, p21-mediated caspase activation and apoptosis", Cell Cycle, vol. 10, no. 23, pp. 4128-4137, 2011.
144. N. R. Jana, P. Dikshit, A. Goswami, and N. Nukina, "Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway", Journal of Biological Chemistry, vol. 279, no. 12, pp. 11680-11685, 2004.
145. T. Choudhuri, S. Pal, M. L. Agwarwal, T. Das, and G. Sa, "Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction", FEBS Letters, vol. 512, no. 1-3, pp. 334-340, 2002.
146. R. Rashmi, S. Kumar, and D. Karunagaran, "Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL", Carcinogenesis, vol. 26, no. 4, pp. 713-723, 2005.
147. S. Shankar and R. K. Srivastava, "Bax and Bakgenes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa", Carcinogenesis, vol. 28, no. 6, pp. 1277-1286, 2007.
148. A. C. Bharti, N. Donato, S. Singh, and B. B. Aggarwal, "Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis", Blood, vol. 101, no. 3, pp. 1053-1062, 2003.
149. R. M. Anson and V. A. Bohr, "Mitochondria, oxidative DNA damage, and aging", Journal of the American Aging Association, vol. 23, no. 4, pp. 199-218, 2000.
150. S. Judge, Y. M. Jang, A. Smith, T. Hagen, and C. Leeuwenburgh, "Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging", The FASEB Journal, vol. 19, no. 3, pp. 419-421, 2005.
151. N. J. Linford, S. E. Schriner, and P. S. Rabinovitch, "Oxidative damage and aging: spotlight on mitochondria", Cancer Research, vol. 66, no. 5, pp. 2497-2499, 2006.
152. M. López-Torres, R. Gredilla, A. Sanz, and G. Barja, "Influence of aging and long-term caloric restriction on oxygen radical generation and oxidative DNA damage in rat liver mitochondria", Free Radical Biology and Medicine, vol. 32, no. 9, pp. 882-889, 2002.
153. Z. Ungvari, N. Labinskyy, S. Gupte, P. N. Chander, J. G. Edwards, and A. Csiszar, "Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats", American Journal of Physiology-Heart and Circulatory Physiology, vol. 294, no. 5, pp. H2121-H2128, 2008.
154. J. J. Smith, R. D. Kenney, D. J. Gagne et al., "Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo", BMC Systems Biology, vol. 3, article 31, 2009.
155. M. G. Novelle, D. Wahl, C. Diéguez, M. Bernier, and R. de Cabo, "Resveratrol supplementation: where are we now and where should we go?" Ageing Research Reviews, vol. 21, pp. 1-15, 2015.
156. I. Sadowska-Bartosz and G. Bartosz, "Effect of antioxidants supplementation on aging and longevity", Bio Med Research International, vol. 2014, Article ID 404680, 17 pages, 2014.
157. J. Marchal, F. Pifferi, and F. Aujard, "Resveratrol in mammals: effects on aging biomarkers, age-related diseases, and life span", Annals of the New York Academy of Sciences, vol. 1290, no. 1, pp. 67-73, 2013.